Sort
8,912 grants matching “sars cov 2”
CEIRR: COVID-19 Research Activities
$987,930Scott Hensley · University Of Pennsylvania · N01 · FY2021 · AI
Towards high-resolution structural biology of membrane protein complexes in their native lipid environment
$987,868Doreen Matthies · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2021 · HD
Implementation of Coordinated Spontaneous Awakening and Breathing Trials Using Telehealth-Enabled, Real-Time Audit and Feedback for Clinician AdHerence: A Type II Hybrid Effectiveness-Implementation
$987,124Colin Kerst Grissom · Ihc Health Services, Inc. · U01 · FY2024 · HL
Enhanced MDx: a computational model to optimize pre-analytical pathogen isolation from whole blood
$987,019Cass T Miller · Redbud Labs, Inc. · R42 · FY2023 · GM
Coronavirus genomics and bioinformatics analysis
$986,465Xiaofang Jiang · National Library Of Medicine · ZIA · FY2021 · LM
Understanding Co-morbidities: COVID-19 in individuals living with HIV/AIDS
$986,355Dhiraj Kumar Singh · Texas Biomedical Research Institute · R01 · FY2024 · AI
Scanning Transmission Electron Tomography of Biological Structures
$986,331Richard Leapman · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2025 · EB
Interactions of SARS-CoV-2 N-protein
$985,108Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2022 · EB
Project 2: Interrogating immuno-metabolic programs using a novel Flow Cytometry based assay to reveal novel T cell subsets in SARS-CoV-2 infected patients
$983,246Jonathan D Powell · Johns Hopkins University · U54 · FY2020 · CA
The longevity and nature of the anti-SARS-CoV-2 cellular and humoral immune responses
$983,100Michel C Nussenzweig · Rockefeller University · P01 · FY2023 · AI
Scientific Core: BSL3 Virology and Animal Models
$983,100Charles M. Rice · Rockefeller University · P01 · FY2023 · AI
Coronavirus neutralizing antibody epitopes and immunogens
$983,100Paul D Bieniasz · Rockefeller University · P01 · FY2023 · AI
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$982,971Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2021 · GM
ASSESSMENT OF ANTI-CARBOHYDRATE IMMUNITY AGAINST SARS-COV-2
$982,346Sri International · · FY2022 · Defense Health Agency
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$981,917Amit Praful Khandhar · Hdt Bio Corporation · R33 · FY2024 · AI
Engineering the Immune Response of a Self-replicating and Adjuvanting RNA HIV-1Vaccine
$981,683Amit Praful Khandhar · Hdt Bio Corporation · R33 · FY2025 · AI
OUR GOAL IS TO INFORM A NATIONAL ACTION PLAN TO HELP THE FOODSERVICE INDUSTRY SKILLFULLY NAVIGATE THE COVID-19 PANDEMIC WITH INCREASED CONFIDENCE. OUR RESEARCH WILL FOCUS ON THE 'FRONT-OF-THE-HOUSE', DEFINED AS ANY LOCATION WITHIN A FOOD SERVICE ESTABLISHMENTS (FSES) WHERE CUSTOMERS ARE ALLOWED. ARGUABLY, THE FOODSERVICE INDUSTRY HAS BEEN THE HARDEST HIT BY THE ONGOING COVID-19 PANDEMIC. SINCE MARCH 2020, 60% OF THE U.S. JOB LOSS HAS BEEN ATTRIBUTED TO THE FOODSERVICE INDUSTRY, PARTIALLY DUE TO LACK OF IN-HOUSE DINING. AS PART OF REOPENING EFFORTS, SOME STATES ARE ALLOWING IN-HOUSE DINING AT A REDUCED CAPACITY, THOUGH SOME CONSUMERS DO NOT FEEL SAFE EATING IN THESE FSES. TO RESTORE CONSUMER CONFIDENCE, WE ASSERT THAT CUSTOMERS NEED TO KNOW THEY WILL NOT BE EXPOSED TO THE SEVERE ACUTE RESPIRATORY SYNDROME (SARS) CORONAVIRUS (COV) TYPE 2 (SARS-COV-2), THE PATHOGEN CAUSING COVID-19. OUR PROPOSED WORK WILL BUILD THE EVIDENCE BASE TO INFORM FSE ENVIRONMENTAL CLEANING PROCEDURES WITH A SPECIFIC FOCUS ON THE FRONT-OF-THE-HOUSE. IMPLEMENTATION OF EFFECTIVE ENVIRONMENTAL CLEANING PROCEDURES IS INSTRUMENTAL IN THE ABILITY OF FSES TO PROVIDE A SAFE DINING EXPERIENCE. THE 4 OBJECTIVES TO ACHIEVE OUR GOAL OF INFORMING A NATIONAL ACTION PLAN ARE:DETERMINE PERSISTENCE OF SARS-COV-2 AND ITS SURROGATES ON ENVIRONMENTAL SURFACES.DEFINE THE TRANSFER RATE OF SARS-COV-2 SURROGATES BETWEEN SURFACES AND HANDS.ESTABLISH THE EFFICACY OF DISINFECTANT STRATEGIES AGAINST SARS-COV-2 AND ITS SURROGATES.DETERMINE THE VALIDITY OF ATP DETECTION TOOLS TO MONITOR ENVIRONMENTAL CLEANING.
$980,526Division Of Agriculture Of The University Of Arkansas · · FY2020 · National Institute of Food and Agriculture
CoVPN 5002: SARS-CoV-2 Prevalence Study - Year 2
$978,683Deborah J Donnell · Fred Hutchinson Cancer Research Center · UM1 · FY2021 · AI
New Technology for High-Resolution Antibody Profiling for SARS-CoV-2
$978,625Mark Lim · Ambergen, Inc · R44 · FY2022 · AI
New Technology for High-Resolution Antibody Profiling for SARS-CoV-2
$978,625Mark Lim · Ambergen, Inc · R44 · FY2023 · AI
Systems Biology Approaches to Viral Pathogenesis and Immunity
$976,964Michael G Katze · Oregon Health & Science University · U54 · FY2012 · AI
University of Pittsburgh Clinical and Translational Science Institute
$976,487Steven E Reis · University Of Pittsburgh At Pittsburgh · UL1 · FY2021 · TR
Unraveling Cytotoxic and Thrombotic Signals in COVID-19
$975,922Yogendra Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2023 · HL
COVID-19 Treatment Cascade Optimization Study
$975,705Liliane Cambraia Windsor · University Of Illinois At Urbana-Champaign · U01 · FY2022 · AI
Portable GC detector for breath-based COVID diagnostics
$975,463Cristina Elizabeth Davis · University Of California At Davis · U18 · FY2021 · TR